Does Rallies show Form 4 insider transactions for PLUR?

Yes. Rallies tracks PLUR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PLUR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PLUR. It does not provide personalized investment advice.

PLUR (Pluri Inc. Common Stock) Stock Analysis - Insider Trades

Pluri Inc. Common Stock (PLUR) is a publicly traded Healthcare sector company. As of May 21, 2026, PLUR trades at $2.60 with a market cap of $33.62M and a P/E ratio of -0.72. PLUR moved +0.00% today. Year to date, PLUR is -13.04%; over the trailing twelve months it is -48.41%. Its 52-week range spans $2.22 to $7.13. Rallies surfaces PLUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PLUR stock inside the company?

Recent PLUR insider activity includes Manieu Alexandre Weinstein bought 452.70K, Manieu Alexandre Weinstein bought 523.44K, Manieu Alexandre Weinstein bought 452.70K, and Aberman Zami sold 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PLUR Key Metrics

Key financial metrics for PLUR
Metric	Value
Price	$2.60
Market Cap	$33.62M
P/E Ratio	-0.72
EPS	$-3.56
Dividend Yield	0.00%
52-Week High	$7.13
52-Week Low	$2.22
Volume	0
Avg Volume	0
Revenue (TTM)	$1.34M
Net Income	$-23.25M
Gross Margin	48.95%

Recent PLUR Insider Trades

Manieu Alexandre Weinstein bought 452.70K (~$2.09M) on Apr 28, 2025.
Manieu Alexandre Weinstein bought 523.44K (~$2.41M) on Apr 28, 2025.
Manieu Alexandre Weinstein bought 452.70K (~$2.09M) on Apr 28, 2025.
Aberman Zami sold 2.00K (~$1.94K) on Dec 20, 2022.

Latest PLUR News

Pluri Chairman Invests $2.5M at 30% Premium in Private Placement — Mar 26, 2026
Pluri Secures China Patent for 3D Cell Expansion, Bolsters Global IP Portfolio — Feb 18, 2026
Pluri Therapeutics Unveils Automated Cell Expansion Platform, Resbiomed Enters Preclinical Stage — Feb 9, 2026

PLUR Analyst Consensus

PLUR analyst coverage data. Average price target: $0.00.

Common questions about PLUR

Who is trading PLUR stock inside the company?: Recent PLUR insider activity includes Manieu Alexandre Weinstein bought 452.70K, Manieu Alexandre Weinstein bought 523.44K, Manieu Alexandre Weinstein bought 452.70K, and Aberman Zami sold 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PLUR?: Yes. Rallies tracks PLUR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PLUR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PLUR. It does not provide personalized investment advice.